- Home
- OOMA vs STRO Comparison
OOMA vs STRO Comparison
Compare OOMA & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OOMA
- STRO
- Stock Information
- Founded
- OOMA 2003
- STRO 2003
- Country
- OOMA United States
- STRO United States
- Employees
- OOMA N/A
- STRO N/A
- Industry
- OOMA EDP Services
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- OOMA Technology
- STRO Health Care
- Exchange
- OOMA Nasdaq
- STRO Nasdaq
- Market Cap
- OOMA 296.9M
- STRO 292.6M
- IPO Year
- OOMA 2015
- STRO 2018
- Fundamental
- Price
- OOMA $14.75
- STRO $2.75
- Analyst Decision
- OOMA Strong Buy
- STRO Strong Buy
- Analyst Count
- OOMA 4
- STRO 7
- Target Price
- OOMA $15.00
- STRO $12.14
- AVG Volume (30 Days)
- OOMA 99.9K
- STRO 851.5K
- Earning Date
- OOMA 12-04-2024
- STRO 11-13-2024
- Dividend Yield
- OOMA N/A
- STRO N/A
- EPS Growth
- OOMA N/A
- STRO N/A
- EPS
- OOMA N/A
- STRO N/A
- Revenue
- OOMA $248,160,000.00
- STRO $160,955,000.00
- Revenue This Year
- OOMA $9.85
- STRO N/A
- Revenue Next Year
- OOMA $6.59
- STRO N/A
- P/E Ratio
- OOMA N/A
- STRO N/A
- Revenue Growth
- OOMA 8.66
- STRO 230.90
- 52 Week Low
- OOMA $6.50
- STRO $2.45
- 52 Week High
- OOMA $15.01
- STRO $6.13
- Technical
- Relative Strength Index (RSI)
- OOMA 73.88
- STRO 37.42
- Support Level
- OOMA $14.32
- STRO $2.55
- Resistance Level
- OOMA $14.16
- STRO $2.76
- Average True Range (ATR)
- OOMA 0.40
- STRO 0.27
- MACD
- OOMA 0.06
- STRO -0.05
- Stochastic Oscillator
- OOMA 84.86
- STRO 15.87
About OOMA Ooma Inc.
Ooma Inc is a communications services company. It is a smart software-as-a-service ("SaaS") and unified communications platform that deliver voice and collaboration features including messaging, intelligent virtual attendants and video conferencing, and residential phone service provides PureVoice high-definition voice quality, advanced functionality and integration with mobile devices. Its services rely upon the following main elements: multi-tenant cloud service, on-premise devices, desktop and mobile applications, and calling platforms. Ooma generates revenues from the sale of subscriptions and other services.
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.